Article Information
History
- November 11, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Tuomo Hartonen1,*,
- Bradley Jermy1,*,
- Hanna Sõnajalg2,
- Pekka Vartiainen1,
- Kristi Krebs2,
- Andrius Vabalas1,
- FinnGen,
- Estonian Biobank Research Team,
- Tuija Leino3,
- Hanna Nohynek3,
- Jonas Sivelä3,
- Reedik Mägi2,
- Mark Daly1,4,5,6,
- Hanna M. Ollila1,4,7,8,
- Lili Milani2,
- Markus Perola3,
- Samuli Ripatti1,4,5,9 and
- Andrea Ganna1,4,5,+
- 1Institute for Molecular Medicine Finland, FIMM, HiLIFE, University of Helsinki, Helsinki, Finland
- 2Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia
- 3The Finnish Institute for Health and Welfare, Helsinki, Finland
- 4Broad Institute of MIT and Harvard, Cambridge, MA, USA
- 5Massachusetts General Hospital, Cambridge, MA, USA
- 6Harvard Medical School, Cambridge, MA, USA
- 7Center of Genomic Medicine, Harvard Medical School, Boston MA, USA
- 8Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- 9Department of Public Health, University of Helsinki, Helsinki, Finland
- ↵+Correspondence should be directed to: andrea.ganna{at}helsinki.fi
↵* These authors contributed equally
Estonian Biobank research team: Andres Metspalu, Tõnu Esko, Reedik Mägi, Mari Nelis and Georgi Hudjashov (email: EstBBresearch{at}ut.ee)